Aristotle University Of Thessaloniki (AUTH)
Ρύθμιση του πυρηνικού υποδοχέα PPARa στην καρδιά σε καταστάσεις μεταβολικού στρες και μετά από επίδραση στατίνης
Abstract
dc:descriptionHeart failure remains one of the leading causes of morbidity and mortality worldwide and is characterized by molecular, cellular and pathophysiological changes in the myocardium. Some of the observed changes refer to lipid and energy homeostasis, which are traits of many cardiovascular diseases. Key transcription regulators of energy metabolism and lipid homeostasis are the peroxisome proliferator-activated receptors (PPARs). Recent clinical studies have shown a significant benefit in the primary prevention and treatment of cardiovascular diseases though the use of lipid-lowering treatment, and mainly through the use of statins. In addition to their hypolipidemic actions, statins display multiple pleiotropic actions, some of which are mediated though PPARs. The aim of this thesis is firstly to investigate the role and regulation of transcription factor PPARα during metabolic stress in the heart and secondly to clarify the underlying molecular mechanisms of PPARα activation by statins. To this purpose, in the first experimental part, the role of PPARα is investigated in the setting of ischemia/reperfusion and diabetes mellitus mediated metabolic stress. Results have shown that under elevated circulating fatty acids, b-oxidation is augmented via PPARα activation. During ischemia/reperfusion in the normal myocardium, the metabolic requirements of the heart are covered mainly by glucose utilization and therefore PPARα expression is downregulated. On the contrary, during ischemia/reperfusion in the diabetic myocardium elevated levels of PPARα seem to maintain fatty acid utilization as energy source at a high level, contributing to resistance against ischemia. However, when a diet rich in cholesterol is applied simultaneously to diabetes, increased susceptibility to ischemic injury is observed. These results indicate that PPARα upregulation might be involved in the mechanisms activated in the diabetic myocardium during the acute phase of the disease to counteract metabolic disorders. Loss of cardioprotection might be potentially related to concomitant disease (hypercholesterolemia) and down-regulation of PPARα. Ιn the second experimental part statin effect and underlying molecular mechanisms leading to activation of PPARα were evaluated. According to the results, in vivo administration of statin results in upregulation and enhanced transcriptional activity of PPARα, that are maintained even following ischemia/reperfusion of the heart. Moreover, statins induce phosphorylation of the ligand-independent part of PPARα receptor at serines 12 and 21 and activate transcriptional activity in isolated cardiomyocytes within 24 hours of statin treatment. Our results have shown that phosphorylation and subsequent activation of PPARα is mediated though ERK1/2 kinases, while the role of phosphorylation by p38 ΜAPK is unclear. Therefore and since during the past few years research has focused on cellular metabolism that seems to play an important role in the pathogenesis of various diseases, a better understanding of the mechanism of PPAR regulation may contribute in the development of pharmaceutical substances for the treatment of cardiovascular diseases.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kelly, Tara
- Κέλλυ, Τάρα
Subjects
dc:subject × 12- Στατίνες, Πλειότροπες δράσεις
- Μεταβολισμός
- Καρδιακή ανεπάρκεια
- Υποδοχείς που ενεργοποιούνται από τους πολλαπλασιαστές των υπεροξειδιοσωμάτων PPARs
- Statins pleiotropic effects
- Metabolism
- Heart failure
- Peroxisome proliferator - activated receptors (PPARs)
- Φυσικές Επιστήμες
- Βιολογία
- Natural Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40344